Install
Your go-to source for the latest news in health, science and medicine. Sign up for STAT+ for exclusive analysis of biotech, pharma, and the life sciences.
- 211articles · 30d
- 1+ day agolatest article
- Aug 14, 2026earliest in window
- 94%with images
- 249avg words
- Medical 154
- Health & Wellness 143
- Health 104
- Science & Technology 48
- Business & Industrial 38
- Economy, Business & Finance 22
- Politics 20
- Politics2 18
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
Medicaid will let states use ‘tiers’ to determine medical frailty
1+ day, 21+ hour ago (529+ words) WASHINGTON — The Centers for Medicare and Medicaid Services this week released guidance for states allowing them to use a “tier system” to determine which Medicaid recipients are too ill to work or volunteer at least 20 hours per week. The decision,…...
I’m a thoracic surgeon in New York City. For many of my patients, Sept. 11 is still not over
2+ day, 11+ hour ago (1035+ words) Retired New York City police officer John Aris sat in my office recently waiting for the results of his latest CT scan. Seven years earlier, I had removed part of his right lung because of cancer. Since then, every follow-up…...
Breast cancer pill from AstraZeneca misses mark in pivotal trial
1+ day, 5+ hour ago (204+ words) STAT is a media company focused on finding and telling compelling stories about health, medicine, and scientific discovery. We produce daily news, investigative articles, and narrative projects in addition to multimedia features, podcasts, and opinion pieces. We tell our stories…...
Scholar Rock wins FDA approval for first drug to target SMA muscle loss
1+ day, 12+ hour ago (214+ words) STAT is a media company focused on finding and telling compelling stories about health, medicine, and scientific discovery. We produce daily news, investigative articles, and narrative projects in addition to multimedia features, podcasts, and opinion pieces. We tell our stories…...
Why two promising heart drugs flopped and what's next
2+ day, 19+ hour ago (222+ words) By Adam Feuerstein, Elaine Chen, and Allison DeAngelis On this week’s episode of “The Readout LOUD”: The pharma industry invested billions of dollars to develop drugs heralded as the next era in the treatment of heart disease — but why did…...
Pharma wins a battle over the cost of wastewater treatment in Europe
1+ day, 14+ hour ago (180+ words) In a boost for the pharmaceutical industry, a European Union Advocate General recommended annulling part of a directive that requires drug and cosmetics manufacturers to finance at least 80% of the costs of wastewater treatment. The directive, which revised an earlier…...
Cancer drug shortages keep disrupting patient care
1+ day, 22+ hour ago (146+ words) Meghana Keshavan is a biotech correspondent at STAT and co-writer of The Readout newsletter. She joined STAT in 2016. She has written about the life sciences industry for more than a decade. Before that, she worked for news outlets like Thomson…...
An AI tool aims to catch harder-to-detect heart attacks in EKGs
2+ day, 11+ hour ago (264+ words) STAT is a media company focused on finding and telling compelling stories about health, medicine, and scientific discovery. We produce daily news, investigative articles, and narrative projects in addition to multimedia features, podcasts, and opinion pieces. We tell our stories…...
Boycott launched against American Diabetes Association includes journal
2+ day, 47+ min ago (743+ words) By Chelsea Cirruzzo, Helen Branswell, and Elizabeth Cooney Good morning. Chelsea Cirruzzo here. Today we remember 25 years since the 9/11 terrorist attacks. While I was too young to have many recollections of the attack, I did grow up in New York…...
Novartis, Novo Nordisk drug failures will likely ‘pop a hole in the balloon’ of the field
2+ day, 12+ hour ago (159+ words) The back-to-back failures of cardiovascular drugs from Novartis and Novo Nordisk made headlines earlier this month. They could also have a chilling effect across the industry. Just before Labor Day, Novartis reported that its cardiac therapy, pelacarsen, failed in a…...